Homepage
Medication Guide
What Are the Side Effects of Alemtuzumab Injection (Lemtrada)?
Alemtuzumab Injection (Lemtrada) is a CD52-directed cytolytic monoclonal antibody used for the treatment of relapsing multiple sclerosis (MS). Despite its significant efficacy, this medication may cau...
510
Wednesday, October 22nd, 2025, 11:11
How to Use Lomitapide (Juxtapid)
Lomitapide (Juxtapid) is a microsomal triglyceride transfer protein (MTP) inhibitor, used for the treatment of homozygous familial hypercholesterolemia (HoFH).How to Use Lomitapide (Juxtapid)Standard ...
507
Wednesday, October 22nd, 2025, 10:35
Indications for Lomitapide (Juxtapid)
Lomitapide (Juxtapid) is a medication used to treat specific lipid metabolism disorders, with lomitapide as its active ingredient.Indications for Lomitapide (Juxtapid)Primary Therapeutic UsesLomitapid...
510
Wednesday, October 22nd, 2025, 10:32
How to Purchase Lomitapide Capsules (Juxtapid)
Lomitapide Capsules (Juxtapid) are an oral microsomal triglyceride transfer protein (MTP) inhibitor indicated for the treatment of homozygous familial hypercholesterolemia (HoFH). Due to the drug’s sp...
510
Wednesday, October 22nd, 2025, 10:26
What Are the Side Effects of Risdiplam Tablets (Evrysdi)?
Risdiplam Tablets (Evrysdi) are an SMN2 splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in children and adults. Available as an oral solution or tablets, its clinical us...
515
Wednesday, October 22nd, 2025, 10:22
Precautions for Risdiplam Tablets (Evrysdi) Administration
Risdiplam Tablets (Evrysdi) are an oral SMN2 splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. As a targeted therapeutic drug requiring lo...
507
Wednesday, October 22nd, 2025, 10:17
How to Use Risdiplam Tablets (Evrysdi)
As the first oral SMN2 splicing modifier, Risdiplam Tablets (Evrysdi) provide an innovative treatment option for patients with spinal muscular atrophy (SMA).How to Use Risdiplam Tablets (Evrysdi)1. Ro...
510
Wednesday, October 22nd, 2025, 10:12
Precautions for Pacritinib (Vonjo) Administration
Pacritinib (Vonjo) is a kinase inhibitor indicated for the treatment of intermediate- or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis in pati...
513
Wednesday, October 22nd, 2025, 10:01
How to Purchase Risdiplam Tablets (Evrysdi)
Risdiplam Tablets (Evrysdi) are an oral SMN2 splicing modifier indicated for the treatment of spinal muscular atrophy (SMA). Due to its specificity and potential risks, strict regulations must be foll...
512
Wednesday, October 22nd, 2025, 09:57
What Are the Side Effects of Pacritinib (Vonjo)?
Pacritinib (Vonjo) is a kinase inhibitor indicated for the treatment of intermediate- or high-risk primary or secondary myelofibrosis in patients with a platelet count below 50×10⁹/L. Although it demo...
513
Wednesday, October 22nd, 2025, 09:53
96 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved